Archive for the ‘Lectureship’ Category

Winner of the 2024 RSC Medicinal Chemistry Emerging Investigator Lectureship

Congratulations to Professor Luca Laraia, recipient of the 2024 RSC Medicinal Chemistry Emerging Investigator Lectureship. 

The annual RSC Medicinal Chemistry Emerging Investigator Lectureship recognises a researcher who has made a significant contribution to medicinal chemistry and drug discovery in their independent academic career, and is open to candidates who received their PhD within the last 10 years. The RSC Medicinal Chemistry Editorial Board have selected Prof Laraia, from the the Technical University of Denmark, as the winner this year. Prof Laraia’s research focuses on the chemical biology of sterol-mediated processes, developing small molecule and protein regulators of cholesterol biosynthesis, metabolism and trafficking, with applications in a range of diseases.

“I am delighted to receive the RSC Medicinal Chemistry Emerging Investigator Lectureship. This is a fantastic recognition of the multidisciplinary work that characterises medicinal chemistry, carried out by our talented group members over the last few years. I am excited to continue to carry out and highlight our work on targeting sterol-mediated processes.” – Prof Luca Laraia

Prof Laraia’s lectureship will be held at a conference later this year, more details to follow. To stay up to date with future announcements, follow us on X (formerly Twitter): @rsc_medchem, LinkedIn: Chemical Biology RSCChemBio and sign-up to our news alerts.

 

More about Luca

Luca Laraia was born in Rome (Italy) and grew up in Vienna (Austria) before moving to London for his MSci degree in chemistry at Imperial College London. He carried out a PhD in medicinal chemistry and chemical biology funded by CRUK at the University of Cambridge, in the labs of Professors David Spring and Ashok Venkitaraman. He then moved to Dortmund as an Alexander von Humboldt post-doctoral research fellow to work at the Max Planck Institute of Molecular Physiology with Professor Herbert Waldmann, before joining the Department of Chemistry at the Technical University of Denmark as an Assistant Professor. Since April 2021 he is an Associate Professor at the same department, leading a research group at the interface of chemistry and biology, focusing on the development of chemical tools and potential therapeutic leads to study and modulate lipid homeostasis. Luca is the recipient of an ERC Starting Grant (2021) and a Hallas Møller Emerging Investigator (2021) from the Novo Nordisk Foundation.

Check out Luca’s recent publications in Chemical Science and ChemComm:

Identification of non-conventional small molecule degraders and stabilizers of squalene synthase (Open Access)

Joseph G. F. Hoock, Cecilia Rossetti, Mesut Bilgin, Laura Depta, Kasper Enemark-Rasmussen, John C. Christianson and Luca Laraia*

Chem. Sci., 2023, 14, 12973-12983

Redshifted and thermally bistable one-way quantitative hemithioindigo-derived photoswitches enabled by isomer-specific excited state intramolecular proton transfer

Mikkel Krell-Jørgensen, Habiburrahman Zulfikri, Magnus Grage Bonnevie, Frederik Simonsen Bro, Asmus Ougaard Dohn and Luca Laraia*

Chem. Commun., 2023, 59, 563-566

Find out more about Luca and follow his lab’s X here at @laraialab.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Winner of the 2023 RSC Medicinal Chemistry Emerging Investigator Lectureship

Congratulations to Dr Christoph Nitsche, recipient of the 2023 RSC Medicinal Chemistry Emerging Investigator Lectureship. 

The annual RSC Medicinal Chemistry Emerging Investigator Lectureship recognises a researcher who has made a significant contribution to medicinal chemistry and drug discovery in their independent academic career, and is open to candidates who received their PhD within the last 10 years. The RSC Medicinal Chemistry Editorial Board have selected Dr Nitsche, from the Australian National University, as the winner this year.

“I am honoured to receive the RSC Medicinal Chemistry Emerging Investigator Lectureship, which I owe first and foremost to my students and postdocs for their tireless efforts over the last couple of years. I was fortunate enough to have had great mentors who inspired me to think outside the box and build interdisciplinary bridges. I am most grateful for the generous support I have received from foundations and funding agencies throughout my early career, as they have provided me the freedom to pursue my ideas.” – Dr Christoph Nitsche

Dr Nitsche’s lectureship will be held virtually at date to be confirmed. To stay up to date with future announcements, follow us on Twitter @rsc_medchem and sign-up to our news alerts.

 

More about Christoph

Dr Nitsche is Associate Professor and ARC Future Fellow at the Australian National University (ANU) in Canberra. He completed his PhD in medicinal chemistry at Heidelberg University, Germany, in 2014 and was awarded a Feodor Lynen Fellowship to undertake postdoctoral work in structural biology at the ANU from 2015 to 2018. After a short period at the Free University of Berlin, he received an ARC Discovery Early Career Research Award in 2019 to return to the ANU as a group leader with the goal to accelerate drug discovery. His most recent honours include the John Wade Early Career Researcher Award, the Peter Schwerdtfeger Award, and the Australian Research Award as top researcher in the field of Medicinal Chemistry. Dr Nitsche’s interdisciplinary research program focuses on infectious diseases, bioorthogonal chemistry, and peptide and protein modification.

Find out more about Christoph and the work his lab is doing on their webpage.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Nominations for the 2023 RSC Medicinal Chemistry Lectureship are now open!

We are delighted to welcome nominations for the 2023 RSC Medicinal Chemistry Emerging Investigator Lectureship

This Lectureship celebrates outstanding early career researchers who have made significant contributions in the fields of medicinal chemistry and drug discovery in their independent careers.

  • This award is presented annually
  • The nominations are shortlisted, and the winner is selected by a judging panel made up of the RSC Medicinal Chemistry Editorial Board
  • The recipient of this award receives the opportunity to present at a relevant high-profile international meeting with a contribution of up to £1,000 to cover associated costs

 

Nominations will close 28 October 2022

 

Past winners of the RSC Medicinal Chemistry Emerging Investigator Lectureship (previously named the MedChemComm Emerging Investigator Lectureship) include:

  • Dr Nir London (Weizmann Institute of Science, Israel) – 2022
  • Dr Jacob Bush (GSK and The Francis Crick Institute, UK) – 2021
  • Dr Chandradhish Ghosh (Max Planck Institute of Colloids and Interfaces, Germany) – 2020
  • Dr Amanda Hargrove (Duke University, USA) – 2019
  • Dr Gonçalo Bernardes (University of Cambridge, UK) – 2018
  • Dr Laura H. Heitman (Leiden University, Netherlands) – 2017
  • Dr Alessio Ciulli (University of Dundee, UK) – 2016
  • Professor Richard Payne (University of Sydney, Australia) – 2015
  • Professor Christian Heinis (École Polytechnique Fédérale de Lausanne, Switzerland) – 2013

Register here to watch a recording of our recent Lectureship webinar featuring our 2021 and 2022 winners, Dr Nir London and Dr Jacob Bush.

Find out more on how to nominate below 


Who can be nominated

The RSC Medicinal Chemistry Lectureship is awarded through a process whereby nominations of candidates are invited from our community.

Open to all researchers globally

As part of the Royal Society of Chemistry, we believe we have a responsibility to promote inclusivity and accessibility to improve diversity. Where possible, we encourage each nominator to consider nominating candidates of all genders, races, and backgrounds. Please see the RSC’s approach to Inclusion and Diversity.

Eligibility

To be eligible for the RSC Medicinal Chemistry Lectureship, the candidate must:

  • Be an active medicinal chemistry researcher, either in academia or industry, carrying out research that is within the scope of the journal
  • Be an independent researcher (this includes Research Associates or Fellows who run their own research group; PhD students and postdocs are not eligible)
  • Be at an early stage of their independent career (this should typically be within 12 years of completing their PhD, but appropriate consideration will be given to those who have taken a career break, followed a different career path or work in systems where their time period to independence may vary). Please contact the Editorial Office if you have any queries

How to nominate

Nominations can be made by anyone and must be sent via email to the Editorial Office. Self-nominations are not permitted. All nominators will be asked to confirm that, to the best of their knowledge, their nominee’s professional standing is such that there is no confirmed or potential impediment to them receiving the Lectureship.

To nominate a candidate, please provide:

  • The name, affiliation, website URL and contact details of the nominee
  • An up-to-date nominee CV (up to 3 pages in length is recommended)
  • A letter of recommendation (500-word limit). Statements as to why a nominee is eligible if they are beyond 12 years of their PhD completion, for instance due to career breaks, will not count towards this word limit
  • Contact details for a confirmed supporting referee. Please inform your referee of the nomination – the Editorial Office will request a supporting letter of recommendation (500-word limit) from this referee once the nomination has been received, where the referee should comment in detail on specific contributions/achievements/potential. Referees must state their relationship with the nominee e.g. this could be the nominee’s postdoc or PhD supervisor, line manager, project manager or academic mentor

Assessment process and selection panel

All eligible nominated candidates will be assessed by a judging panel made up of the RSC Medicinal Chemistry Editorial Board. Any Editorial Board members who have a conflict of interest will be removed from the selection panel.

The judging panel will consider the following core criteria:

  • Excellence in research, as evidenced with reference to originality and impact
  • Quality of publications/patents/software
  • Innovation
  • Professional standing
  • Independence
  • Collaborations and teamwork
  • Evidence of promising potential
  • Other indicators of esteem indicated by the nominator or referee

In any instance where multiple nominees are judged equally meritorious in relation to these core criteria, the judging panel will use information provided on the nominee’s broader contribution to the chemistry community as an additional criterion. Examples of this could include:

  • Involvement with RSC community activities
  • Teaching/demonstrating
  • Effective mentorship
  • Service on boards, committees or panels
  • Leadership in the scientific community
  • Peer-reviewing
  • Promotion of diversity and inclusion
  • Advocacy for chemistry
  • Public engagement and outreach

 

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Winner of the 2022 RSC Medicinal Chemistry Emerging Investigator Lectureship

Congratulations to Dr Nir London, recipient of the 2022 RSC Medicinal Chemistry Emerging Investigator Lectureship. 

The annual RSC Medicinal Chemistry Emerging Investigator Lectureship recognises a researcher who has made a significant contribution to medicinal chemistry and drug discovery in their independent academic career, and is open to candidates who received their PhD within the last 10 years. The RSC Medicinal Chemistry Editorial Board have selected Dr. London, from the Weizmann Institute of Science, as the winner this year.

I am honoured and humbled to receive the 2022 RSC Medicinal Chemistry Emerging Investigator Lectureship. This would not have been possible without the support of my mentors and colleagues throughout the years and the hard work of my students, post-docs and trainees. I look forward to continued interactions with the wonderful medicinal chemistry community.” – Dr Nir London

Dr London’s lectureship will be held virtually at date to be confirmed. To stay up to date with future announcements, follow us on Twitter @rsc_medchem and sign-up to our news alerts.

 

More about Nir

Dr. Nir London completed his PhD in computational structural biology at the Hebrew University in 2012. He then pursued a post-doctoral fellowship with Brian Shoichet at UCSF where he developed a pioneering virtual screening platform for covalent inhibitor discovery. In 2015 Dr. London joined the Weizmann Institute of Science, where he is currently the Alan and Laraine Fischer Career Development Chair in the Dept. of Chemical and Structural Biology. Dr. London’s lab is focused on covalent chemical biology and drug discovery and is developing new technologies to discover and functionalize covalently acting compounds. His honors include amongst others the Alon fellowship, the EFMC award for young medicinal chemist in academia and the ICBS award for young chemical biologist.

Find out more about Nir and the work his lab is doing on their webpage.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Announcing the 2021 RSC Medicinal Chemistry Emerging Investigator Lectureship winner

Photo of Dr Jacob Bush

Dr Jacob Bush

Congratulations to Dr Jacob Bush, recipient of the 2021 RSC Medicinal Chemistry Emerging Investigator Lectureship.

The Lectureship was open to any candidate who received their PhD in 2011 or later and has made a significant contribution to medicinal chemistry in their early career. The RSC Medicinal Chemistry Editorial Board selected Dr. Bush, from GSK, from a short-list of nominees.

Many congratulations to Dr. Bush for winning the lectureship.

When he was informed of his selection, Dr. Bush said:

It’s a privilege to receive this lectureship as it recognises cutting edge work in chemical biology by a team of outstanding scientists both at GSK and at our academic partner institutions.  Building these innovative technologies for agile target validation is key to GSK’s differentiated approach to identify, select and develop more genetically validated targets which have higher likelihood of success.”

 

About Dr Bush:

Dr Jacob Bush works in medicinal chemistry & chemical biology at GSK, leading the development of new technologies to accelerate drug discovery, in particular through innovations in chemical biology and artificial intelligence (AI). He works between GSK, where he is group leader in the chemical biology department and The Francis Crick Institute, where he is an active member of the leadership team of the GSK-Crick LinkLabs collaboration.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Nominations for 2021 RSC Medicinal Chemistry Emerging Investigator Lectureship Open

We are pleased to welcome nominations for the 2021 RSC Medicinal Chemistry Emerging Investigator Lectureship. The Lectureship celebrates early career researchers who have made significant contributions in the fields of medicinal chemistry and drug discovery.

Nominations will close 30 November 2020.

The recipient of the lectureship will receive a contribution of up to £1000 towards speaking at a conference in 2021. We recognise many researchers’ travel plans for 2021 are uncertain, and are flexible in accommodating speaking engagements at digital conferences.

Eligibility:
The lectureship is open to candidates who received their PhD in 2011 or later and who have made a significant contribution to medicinal chemistry in their early career, particularly if they have brought new ideas to drug discovery.

How you can nominate:
If you would like to nominate someone please email medchem-rsc@rsc.org with the following details:

  • Their name
  • Their affiliation
  • At least one paragraph explaining their achievements and why you think they should be considered

Additional supporting information, for example their CV, is very helpful in making a decision but is not mandatory for making a nomination.

Self-nominations are accepted but must be supported by a letter of support from your Head of Department or similar person at your institute.

Selection:
All qualified nominations will be considered and a short-list of candidates will be selected based on the information provided at nomination. The RSC Medicinal Chemistry Editorial Board will then vote to select the recipient and the winner will be announced in early 2021.

Past winners of the RSC Medicinal Chemistry Emerging Investigator Lectureship (previously named the MedChemComm Emerging Investigator Lectureship) include:

  • Dr Chandradhish Ghosh (Max Planck Institute of Colloids and Interfaces) – 2020
  • Dr. Amanda Hargrove (Duke University, USA) – 2019
  • Dr. Gonçalo Bernardes (University of Cambridge, UK) – 2018
  • Dr Laura H. Heitman (Leiden University, Netherlands) – 2017
  • Dr Alessio Ciulli (University of Dundee, UK) – 2016
  • Professor Richard Payne (University of Sydney, Australia) – 2015
Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

2020 RSC Medicinal Chemistry Lectureship Winner

Congratulations to Dr. Chandradhish Ghosh, the recipient of the 2020 RSC Medicinal Chemistry Emerging Investigator Lectureship!

Chandradhish GhoshThe Lectureship was open to any candidate who received their PhD in 2010 or later and has made a significant contribution to medicinal chemistry in their early career. The RSC Medicinal Chemistry Editorial Board selected Dr. Ghosh, from Max Planck Institute of Colloids and Interfaces, Germany, from a short-list of nominees.

Many congratulations to Dr. Ghosh for winning the lectureship.

When he was informed of his selection, Dr. Ghosh said:

I feel humbled to be recognized by scientists who inspire me. It motivates me to strive harder to solve the problems of human diseases. This would not have been possible without the support of fantastic mentors, colleagues, collaborators, teachers, friends and family.”

About Chandradhish

Dr. Chandradhish Ghosh performed his doctoral studies at Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, under the supervision of Prof. Jayanta Haldar, after first earning his MSc in Chemistry at the University of Delhi. Since 2017, he has been working at the Max Planck Institute for Colloids and Interfaces, in the group of Prof. Peter H. Seeberger. His current work focusses on targeting neglected tropical diseases.

His doctoral work on membrane-active small molecules against drug-resistant pathogens has led to an anti-Ebola drug candidate. He has contributed to the sum of knowledge in the field by the publication of several highly cited reviews. He has won several awards, including the prestigious Gandhian Young Technological Innovation Award in 2015.

To show the range of his scientific work, some of Dr. Ghosh’s recent works are below:

A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics

Med. Chem. Commun., 2017, 8, 516-533

l-Lysine based lipidated biphenyls as agents with anti-biofilm and anti-inflammatory properties that also inhibit intracellular bacteria

Chem. Commun., 2017, 53, 8427-8430

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Nominations for the 2020 RSC Medicinal Chemistry Emerging Investigator Lectureship are now open!

The 2020 RSC Medicinal Chemistry Emerging Investigator Lectureship is now open for nominations. The Lectureship celebrates early career researchers who have made significant contributions in the fields of medicinal chemistry and drug discovery.

Nominations will close 31 January 2020.

The recipient of the lectureship will receive a contribution of up to £1000 towards speaking at a conference in 2020.

Qualification
The lectureship is open to candidates who received their PhD in 2010 or later and who have made a significant contribution to medicinal chemistry in their early career, particularly if they have brought new ideas to drug discovery.

How you can nominate
If you would like to nominate someone please email us (medchem-rsc@rsc.org) with the following details:

  • Their name
  • Their affiliation
  • At least one paragraph explaining their achievements and why you think they should be considered

Additional supporting information, for example their CV, is very helpful in making a decision but is not mandatory for making a nomination.

Self-nominations are accepted but must be supported by a letter of support from your Head of Departments or similar person at your institute.

Selection
All qualified nominations will be considered and a short-list of candidates with be selected based on the information provided at nomination. The RSC Medicinal Chemistry Editorial Board will then vote to select the recipient and the winner will be announced in spring 2020.

Past winners of the RSC Medicinal Chemistry Emerging Investigator Lectureship (previously named the MedChemComm Emerging Investigator Lectureship) include:

  • Dr. Amanda Hargrove (Duke University, USA) – 2019
  • Dr. Gonçalo Bernardes (University of Cambridge, UK) – 2018
  • Dr Laura H. Heitman (Leiden University, Netherlands) – 2017
  • Dr Alessio Ciulli (University of Dundee, UK) – 2016
  • Professor Richard Payne (University of Sydney, Australia) – 2015
  • Professor Christian Heinis (École Polytechnique Fédérale de Lausanne, Switzerland) – 2013
  • Professor Patrick Gunning (University of Toronto, Canada) – 2012
Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

2019 MedChemComm Emerging Investigator Lectureship – nominations open

The 2019 MedChemComm Emerging Investigator Lectureship is now open for nominations.

Nominations will close 22 November 2018.

The recipient of the lectureship will receive a contribution of up to £1000 towards speaking at a conference in 2019.

Qualification
The lectureship is open to candidates who received their PhD in 2009 or later and who have made a significant contribution to medicinal chemistry in their early career, particularly if they have brought new ideas to drug discovery.

How you can nominate
If you would like to nominate someone please email us (medchemcomm-rsc@rsc.org) with the following details:

  • Their name
  • Their affiliation
  • At least one paragraph explaining their achievements and why you think they should be considered

Additional supporting information, for example their CV, is very helpful in making a decision but is not mandatory for making a nomination.

Self-nominations are accepted but must be supported by a letter of support from your Head of Departments or similar person at your institute.

Selection
All qualified nominations will be considered and a short-list of candidates with be selected based on the information provided at nomination. The MedChemComm Editorial Board will then vote to select the recipient and the winner will be announced in late 2018.

Previous lectureship winners include:

  • Dr. Gonçalo Bernardes (University of Cambridge, UK) – 2018
  • Dr Laura H. Heitman (Leiden University, Netherlands) – 2017
  • Dr Alessio Ciulli (University of Dundee, UK) – 2016
  • Professor Richard Payne (University of Sydney, Australia) – 2015
  • Professor Christian Heinis (École Polytechnique Fédérale de Lausanne, Switzerland) – 2013
  • Professor Patrick Gunning (University of Toronto, Canada) – 2012
Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Dr. Gonçalo Bernardes wins the 2018 Emerging Investigator Lectureship

We are delighted to announce that Dr. Gonçalo Bernardes has been selected to receive the 2018 MedChemComm Emerging Investigator Lectureship

The lectureship was open to any candidate who received their PhD in 2008 or later and have made a significant contribution to medicinal chemistry in their early career. The Editorial Board feel that his substantial contributions to the chemistry of protein conjugates, and his impact on the field of antibody conjugates make him an excellent choice for this year’s lectureship.

On being informed of his selection Dr. Bernardes said:

I am honoured to receive this distinction from an organisation I admire so much and so incredibly proud of the work of my entire research group at Cambridge and iMM Lisbon.”

Dr. Bernardes will give his lecture later this year at a conference to be confirmed.

About Dr. Gonçalo Bernardes

Dr. Gonçalo Bernardes is a Group Leader at the Department of Chemistry, University of Cambridge, U.K.. He is also the Director of the Chemical Biology and Pharmaceutical Biotechnology Unit at the Instituto de Medicina Molecular, Portugal. After completing his D.Phil. degree in 2008 at the University of Oxford, U.K., he undertook postdoctoral work at the Max-Planck Institute of Colloids and Interfaces, Germany, and the ETH Zürich, Switzerland, and worked as a Group Leader at Alfama Lda in Portugal. He started his independent research career in 2013, and his research group tackles a range of biological problems of fundamental importance to understand and fight human disease primarily through the use of chemistry principles. He is a Royal Society University Research Fellow and the awardee of a Starting Grant from the European Research Council (TagIt).

Visit Gonçalo’s homepage to find out more about his ongoing research.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)